These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

537 related items for PubMed ID: 9756642

  • 1. Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery.
    Samoilova EB, Horton JL, Chen Y.
    Cell Immunol; 1998 Sep 15; 188(2):118-24. PubMed ID: 9756642
    [Abstract] [Full Text] [Related]

  • 2. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells.
    Samoilova EB, Horton JL, Hilliard B, Liu TS, Chen Y.
    J Immunol; 1998 Dec 15; 161(12):6480-6. PubMed ID: 9862671
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL-4-deficient C57BL/6 mice and BALB/c mice.
    Falcone M, Rajan AJ, Bloom BR, Brosnan CF.
    J Immunol; 1998 May 15; 160(10):4822-30. PubMed ID: 9590229
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG(35-55)-induced experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Furlan R, Bergami A, Brambilla E, Butti E, De Simoni MG, Campagnoli M, Marconi P, Comi G, Martino G.
    Gene Ther; 2007 Jan 15; 14(1):93-8. PubMed ID: 16929354
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE.
    Isaksson M, Ardesjö B, Rönnblom L, Kämpe O, Lassmann H, Eloranta ML, Lobell A.
    Eur J Immunol; 2009 Oct 15; 39(10):2925-35. PubMed ID: 19637225
    [Abstract] [Full Text] [Related]

  • 11. Evidence that Fas and FasL contribute to the pathogenesis of experimental autoimmune encephalomyelitis.
    Dittel BN.
    Arch Immunol Ther Exp (Warsz); 2000 Oct 15; 48(5):381-8. PubMed ID: 11140465
    [Abstract] [Full Text] [Related]

  • 12. Methylprednisolone induces reversible clinical and pathological remission and loss of lymphocyte reactivity to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis.
    Chan J, Ban EJ, Chun KH, Wang S, McQualter J, Bernard C, Toh BH, Alderuccio F.
    Autoimmunity; 2008 Aug 15; 41(5):405-13. PubMed ID: 18568646
    [Abstract] [Full Text] [Related]

  • 13. Experimental autoimmune encephalomyelitis in intercellular adhesion molecule-1-deficient mice.
    Samoilova EB, Horton JL, Chen Y.
    Cell Immunol; 1998 Nov 25; 190(1):83-9. PubMed ID: 9826450
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
    Murphy AC, Lalor SJ, Lynch MA, Mills KH.
    Brain Behav Immun; 2010 May 25; 24(4):641-51. PubMed ID: 20138983
    [Abstract] [Full Text] [Related]

  • 16. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein.
    Lyons JA, Ramsbottom MJ, Cross AH.
    Eur J Immunol; 2002 Jul 25; 32(7):1905-13. PubMed ID: 12115610
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.